secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001773751-25-000152
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q1 revenue $586M (+111% YoY), net income $49.5M, raises EBITDA guidance
--------------------------------------------------------------------------------

- Revenue $586M (+111% YoY); net income $49.5M (up 345% YoY); Adj. EBITDA $91.1M (up 182% YoY).
- Subscribers 2.4M (+38% YoY); monthly online rev per sub $84 (+53% YoY).
- Affirms FY2025 revenue guidance $2.3-$2.4B; raises Adj. EBITDA outlook to $295-$335M.
- Introduced 2030 targets of at least $6.5B revenue and $1.3B Adj. EBITDA.
- Gross margin 73% (down 900bps YoY) on GLP-1 mix; partnered with Novo Nordisk for Wegovy access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000152/0001773751-25-000152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000152/hims-20250505.htm
  HTML page:      https://secwatch.observer/filing/0001773751-25-000152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer